Torrent Pharma Q3 result: Net profit up 26% at ₹635 cr, dividend declared

Torrent Pharma Q3 revenue from operations increased 17.7 per cent year-on-year (Y-o-Y) to ₹3,251 crore from ₹2,762 crore in Q3FY25

Torrent Pharmaceuticals on Friday reported a 26.2 per cent jump in its consolidated net profit to ₹635 crore in the third quarter of the financial year 2025-26 (Q3FY26). During the same quarter last year, the company recorded a profit of ₹503 crore. On a sequential basis, profit increased 7.4 per cent from ₹591 crore. The company attributed the surge to robust branded business performance across markets.

 

The company's revenue from operations for the quarter increased 17.7 per cent year-on-year (Y-o-Y) to ₹3,251 crore from ₹2,762 crore in Q3FY25. Sequentially, the revenue was flat from ₹3,246 crore.

 

Its earnings before interest, taxes, depreciation and amortisation (Ebitda) for the quarter stood at ₹1,088 crore, up 17 per cent Y-o-Y. 

 

 

Torrent Pharma dividend announced

 

Torrent Pharma also announced an interim dividend of ₹29 per share. "The dividend is expected to be paid/dispatched on or around March 5, 2026," it added.

 

Torrent Pharma Q3 performance across markets

• India: Revenue at ₹1,798 crore, up 14 per cent
• Brazil: Revenue at ₹371 crore, up 27 per cent
• United States: Revenue at ₹321 crore, up 19 per cent
• Germany: Revenue at ₹304 crore, up 8 per cent

Shares of Torrent Pharmaceuticals closed largely flat at ₹4,074.05 apiece on the BSE on Friday, ahead of the result announcement.